INTERNALIZED STIGMA IN PATIENTS WITH SCHIZOPHRENIA: A HOSPITAL-BASED CROSS-SECTIONAL STUDY FROM NEPAL


Future of anti-VEGF: biosimilars and biobetters

Abstract The advent of Anti- VEGFs like Lucentis (Ranibizumab), Eylea (Aflibercept) and off-label dome Avastin (Bevacizumab) have radically improved visual outcomes in patients of neovascular Age Related Macular Degeneration (nARMD), Diabetic Macular Edema (DME) and Retinal Vein Occlusion (RVO).It is a matter of great concern that the US patents fo

read more